Firms
Jefferson Life Sciences
Life sciences investment firm within Jefferson River Capital, launched in 2025 and based in New York. Invests in therapeutic platforms from early development through commercialization, using flexible private and public investment structures. Its portfolio includes AI-enabled regenerative biologics, precision ophthalmology and neuroscience drug development.
- Founded
- 2025
- Type
- Venture capital
Funds0
No funds on record yet.
Team
Operations and support
 Charles S. CarignanStrategic Advisor |
 Cristina GhenoiuStrategic Advisor |
 Hunter RogersSenior Associate |
 Jason P. HaflerStrategic Advisor |
 Jim WeissmanStrategic Advisor |
 Laura Lande-DinerManaging Partner |
 Michal PremingerStrategic Advisor |
 Sangeeta N. BhatiaStrategic Advisor |
 Stanton GersonStrategic Advisor |
 Thomas ZapadkaInvestment Analyst |
 Uli StilzStrategic Advisor |
Co-investing
aMoon
Character Biosciences$93M · 2025-03-25
Bison Ventures
Juvena Therapeutics$33M · 2026-01-12
British Business Bank
Draig Therapeutics$65M · 2026-07-14
Casdin Capital- Character Biosciences$93M · 2025-03-25
Catalio Capital Management- Character Biosciences$93M · 2025-03-25
Deep Track Capital
- Draig Therapeutics$65M · 2026-07-14
Eli Lilly and Company
- Juvena Therapeutics$33M · 2026-01-12
Innovation Endeavors- Character Biosciences$93M · 2025-03-25
Janus Henderson Investors
- Draig Therapeutics$65M · 2026-07-14
Manta Ray
- Juvena Therapeutics$33M · 2026-01-12
Marshall Wace
- Draig Therapeutics$65M · 2026-07-14
Mubadala Capital- Juvena Therapeutics$33M · 2026-01-12
S32- Character Biosciences$93M · 2025-03-25
Sanofi Ventures
- Character Biosciences$93M · 2025-03-25